Comparable stake leader
INTEGRATED CORE STRATEGIES (US) LLC
SEC ownership of ARDELYX, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001437402.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
20 Apr 2026
- Public ticker
- ARDX on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
INTEGRATED CORE STRATEGIES (US) LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
INTEGRATED CORE STRATEGIES (US) LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
20 Apr 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001437402
- Issuer location
- Fremont, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ARDELYX, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTEGRATED CORE STRATEGIE...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
20 Apr 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.4%
13D/G row: INTEGRATED CORE STRATEGIES (US) LLC
Showing 1-8 of 50 holder rows.
Quick read
INTEGRATED CORE STRATEGIES (US) LLC leads the comparable SEC ownership view at 7.4%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTEGRATED CORE STRATEGIES (US) LLC's linked filing trail.
Comparable ownership
Top 5
INTEGRATED CORE STRATEGIES (US) LLC
7.4%
STATE STREET CORP
5.5%
JANUS HENDERSON GROUP PLC
3.4%
MILLENNIUM MANAGEMENT LLC
3.2%
Edward R. Conner
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
7.4%
|
$108,083,380
18,043,970 shares
|
+$29,483,912 | 31 Mar 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
5.5%
|
$83,122,316
13,604,307 shares
|
+$12,289,611 | 31 Mar 2026 |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
3.4%
|
$51,148,240
8,371,234 shares
|
-$33,316,968 | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
Company
|
3.2%
from 13D/G
|
$106,875,796
17,842,370 shares
|
— | 31 Mar 2026 |
| Edward R. Conner |
3/4/5
Chief Medical Officer
|
0.12%
|
$1,665,452
302,260 shares
|
— | 01 Aug 2025 |
| Felecia Ettenberg |
3/4/5
Chief Legal Officer
|
0.1%
|
$1,419,630
237,000 shares
|
— | 20 Apr 2026 |
| Rajani Dinavahi |
3/4/5
Chief Medical Officer
|
0.08%
|
$1,171,830
201,000 shares
|
— | 01 Apr 2026 |
| BlackRock, Inc. |
13F
Company
|
8.6%
|
$126,773,151
21,164,132 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$2,656,043.
Buys
$1,946,331
Insiders: 1
Sells
$4,602,374
Insiders: 10
Net
-$2,656,043
Shares: -427,463
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 333,333
Shares: 760,796
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 293,207 | $0 | $1,791,342 | -$1,791,342 |
| 3-6 | 333,333 | 220,270 | $1,946,331 | $1,361,148 | +$585,183 |
| 6-9 | 0 | 81,768 | $0 | $452,741 | -$452,741 |
| 9-12 | 0 | 165,551 | $0 | $997,143 | -$997,143 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 29 reporting-owner rows connected to ARDELYX, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
29
Largest Forms 3/4/5 holder
David M. Mott
Net 12M change
-$2,656,043
Latest report
18 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| David M. Mott | Director | $20,064,433 | +$1,946,331 | +11% | Median | 16 Jun 2026 |
| Forest Baskett | 10%+ Owner | $14,998,764 | Mixed | 09 Dec 2021 | ||
| Scott D. Sandell | 10%+ Owner | $14,998,764 | Mixed | 09 Dec 2021 | ||
| Michael Raab | President & CEO, Director | $10,657,599 | -$2,406,447 | -18% | Mixed | 15 Jun 2026 |
| Susan Rodriguez | Chief Commercial Officer | $3,844,258 | Mixed | 21 May 2024 | ||
| Eric D. Foster | Chief Commercial Officer | $3,095,283 | -$234,155 | -7% | Mixed | 21 May 2026 |
| Justin A. Renz | Chief Financial Officer | $2,902,017 | -$41,741 | -1.4% | Mixed | 21 Aug 2025 |
| Mike Kelliher | Chief Business Officer | $2,715,761 | -$164,443 | -5.7% | Mixed | 21 May 2026 |
| Richard J. Rodgers | Director | $2,635,588 | Median | 16 Jun 2026 | ||
| Laura A. Williams | Chief Patient Officer | $2,630,873 | -$1,493,393 | -36% | Mixed | 18 Jun 2026 |
| David P. Rosenbaum | Chief Development Officer | $2,521,763 | Mixed | 20 Nov 2024 | ||
| Elizabeth A. Grammer | Chief Legal and Administrative Officer | $2,136,132 | -$67,841 | -3.1% | Mixed | 21 Nov 2025 |
| John E. Bishop | Chief Technical and Quality Officer | $2,111,176 | -$33,039 | -1.5% | Filing P/S | 21 May 2026 |
| William C. Bertrand Jr. | Director | $2,067,110 | Mixed | 16 Jun 2026 | ||
| Robert Blanks | Chief Regulatory and Quality Affairs Officer | $1,843,891 | Mixed | 20 Nov 2024 | ||
| Edward R. Conner | Chief Medical Officer | $1,665,452 | Mixed | 01 Aug 2025 | ||
| James Parker Brady | Chief Human Resources Officer | $1,636,231 | -$26,438 | -1.6% | Filing P/S | 21 May 2026 |
| Susan Hohenleitner | Chief Financial Officer | $1,435,746 | -$21,005 | -1.4% | Filing P/S | 21 May 2026 |
| Felecia Ettenberg | Chief Legal Officer | $1,419,630 | Median | 20 Apr 2026 | ||
| Rajani Dinavahi | Chief Medical Officer | $1,171,830 | Mixed | 01 Apr 2026 |
Recent insider transactions for ARDELYX, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Laura A. Williams | ARDX | Common Stock | Sale | -17.8% | $490,487 | $5.99 | -81,898 | 378,195 | 18 Jun 2026 | Direct |
| Laura A. Williams | ARDX | Common Stock | Options Exercise | 7.22% | 31,000 | 460,093 | 18 Jun 2026 | Direct | ||
| Laura A. Williams | ARDX | Stock Option (Right to Buy) | Options Exercise | -50% | -31,000 | 31,000 | 18 Jun 2026 | Direct | ||
| Merdad Parsey | ARDX | Common Stock | Award | 46.2% | 26,455 | 83,746 | 16 Jun 2026 | Direct | ||
| Merdad Parsey | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| Richard J. Rodgers | ARDX | Common Stock | Award | 6.4% | 26,455 | 439,998 | 16 Jun 2026 | Direct | ||
| Richard J. Rodgers | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| David M. Mott | ARDX | Common Stock | Award | 1.42% | 46,737 | 3,349,655 | 16 Jun 2026 | Direct | ||
| David M. Mott | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| Onaiza Cadoret-Manier | ARDX | Common Stock | Award | 17.4% | 26,455 | 178,156 | 16 Jun 2026 | Direct | ||
| Onaiza Cadoret-Manier | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| Muna Bhanji | ARDX | Common Stock | Award | 19.3% | 26,455 | 163,808 | 16 Jun 2026 | Direct | ||
| Muna Bhanji | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| William C. Bertrand Jr. | ARDX | Common Stock | Award | 13.4% | 38,800 | 329,507 | 16 Jun 2026 | Direct | ||
| William C. Bertrand Jr. | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| Robert B. Bazemore | ARDX | Common Stock | Award | 63.7% | 26,455 | 68,006 | 16 Jun 2026 | Direct | ||
| Robert B. Bazemore | ARDX | Stock Option (Right to Buy) | Award | 39,715 | 39,715 | 16 Jun 2026 | Direct | |||
| Michael Raab | ARDX | Common Stock | Sale | -2.39% | $236,346 | $5.67 | -41,666 | 1,699,200 | 15 Jun 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Options Exercise | 1.21% | 20,833 | 1,740,866 | 15 Jun 2026 | Direct | ||
| Michael Raab | ARDX | Stock Option (Right to Buy) | Options Exercise | -6.27% | -20,833 | 311,668 | 15 Jun 2026 | Direct | ||
| Joseph J. Reilly | ARDX | Common Stock | Sale | -2.43% | $23,309 | $6.27 | -3,719 | 149,107 | 21 May 2026 | Direct |
| Susan Hohenleitner | ARDX | Common Stock | Sale | -0.63% | $9,119 | $6.27 | -1,455 | 229,078 | 21 May 2026 | Direct |
| John E. Bishop | ARDX | Common Stock | Sale | -0.68% | $14,453 | $6.27 | -2,306 | 336,845 | 21 May 2026 | Direct |
| James Parker Brady | ARDX | Common Stock | Sale | -0.7% | $11,570 | $6.27 | -1,846 | 261,066 | 21 May 2026 | Direct |
| Eric D. Foster | ARDX | Common Stock | Sale | -1.88% | $50,127 | $6.27 | -7,998 | 417,972 | 21 May 2026 | Direct |
| Mike Kelliher | ARDX | Common Stock | Sale | -1.99% | $45,427 | $6.27 | -7,248 | 357,418 | 21 May 2026 | Direct |
| Laura A. Williams | ARDX | Common Stock | Sale | -1.6% | $43,804 | $6.27 | -6,989 | 429,093 | 21 May 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Sale | -3.08% | $343,133 | $6.27 | -54,748 | 1,720,033 | 21 May 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Sale | -2.29% | $261,612 | $6.28 | -41,666 | 1,774,781 | 15 May 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Options Exercise | 1.16% | 20,833 | 1,816,447 | 15 May 2026 | Direct | ||
| Michael Raab | ARDX | Stock Option (Right to Buy) | Options Exercise | -5.9% | -20,833 | 332,501 | 15 May 2026 | Direct | ||
| Michael Raab | ARDX | Common Stock | Sale | -2.27% | $261,954 | $6.29 | -41,668 | 1,795,614 | 15 Apr 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Options Exercise | 1.15% | 20,834 | 1,837,282 | 15 Apr 2026 | Direct | ||
| Michael Raab | ARDX | Stock Option (Right to Buy) | Options Exercise | -5.57% | -20,834 | 353,334 | 15 Apr 2026 | Direct | ||
| Michael Raab | ARDX | Common Stock | Sale | -2.24% | $243,329 | $5.84 | -41,666 | 1,816,448 | 16 Mar 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Options Exercise | 1.13% | 20,833 | 1,856,986 | 16 Mar 2026 | Direct | ||
| Michael Raab | ARDX | Stock Option (Right to Buy) | Options Exercise | -5.27% | -20,833 | 374,168 | 16 Mar 2026 | Direct | ||
| Michael Raab | ARDX | Common Stock | Sale | -2.22% | $260,621 | $6.26 | -41,666 | 1,836,153 | 24 Feb 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Options Exercise | 1.12% | 20,833 | 1,877,819 | 24 Feb 2026 | Direct | ||
| Michael Raab | ARDX | Stock Option (Right to Buy) | Options Exercise | -5.01% | -20,833 | 395,001 | 24 Feb 2026 | Direct | ||
| David M. Mott | ARDX | Common Stock | Purchase | 11.2% | $1,946,331 | $5.84 | 333,333 | 3,302,918 | 20 Feb 2026 | Direct |
| John E. Bishop | ARDX | Common Stock | Sale | -0.93% | $18,586 | $5.85 | -3,179 | 339,151 | 20 Feb 2026 | Direct |
| Joseph J. Reilly | ARDX | Common Stock | Sale | -3.18% | $29,181 | $5.85 | -4,991 | 151,790 | 20 Feb 2026 | Direct |
| Laura A. Williams | ARDX | Common Stock | Sale | -1.84% | $47,803 | $5.85 | -8,176 | 436,082 | 20 Feb 2026 | Direct |
| Susan Hohenleitner | ARDX | Common Stock | Sale | -0.87% | $11,886 | $5.85 | -2,033 | 230,533 | 20 Feb 2026 | Direct |
| James Parker Brady | ARDX | Common Stock | Sale | -0.96% | $14,868 | $5.85 | -2,543 | 262,912 | 20 Feb 2026 | Direct |
| Mike Kelliher | ARDX | Common Stock | Sale | -2.56% | $56,099 | $5.85 | -9,595 | 364,666 | 20 Feb 2026 | Direct |
| Michael Raab | ARDX | Common Stock | Sale | -2.42% | $268,841 | $5.85 | -45,982 | 1,856,986 | 20 Feb 2026 | Direct |
| Eric D. Foster | ARDX | Common Stock | Sale | -2.39% | $61,034 | $5.85 | -10,439 | 425,970 | 20 Feb 2026 | Direct |
| Joseph J. Reilly | ARDX | Common Stock | Award | 41.8% | 46,200 | 156,781 | 23 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.